VMY-1-103

CAT: 0013-GTR19208154-01Size: 25 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19208154-01Size:25 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

VMY-1-103 is a potent dansylated CDK inhibitor derived from purvalanol B. It demonstrates superior antiproliferative and pro-apoptotic activity in vitro against prostate, breast, and medulloblastoma cancer cells by inducing cell cycle arrest and activating intrinsic and extrinsic apoptotic pathways.

CAS Number

1209002-43-6

Field of Research

Cell Biology, Protein Biochemistry

Smiles

N (C1=C2C (N (C (C) C) C=N2) =NC (N[C@H] (C (C) C) CO) =N1) C3=CC (Cl) =C (C (NCCNS (=O) (=O) C=4C5=C (C (N (C) C) =CC=C5) C=CC4) =O) C=C3

Molecular Formula

C34H42ClN9O4S

Molecular Weight

708.27

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19208153-01	VMY-1-101
GTR19192444-01	VMY-2-95
GTR19208471-01	BRN-103
GTR19171705-01	PI-103
GTR19192240	YPH 103
GTR19249185-01	DS-103
GTR19274553-01	α-Glucosidase-IN-103
GTR19201406-01	ICP 103
GTR19237995-01	HSD17B13-IN-103
GTR19235415-01	EGFR-IN-103

Alternative Products

Catalog	Name
T71230-01	VMY-1-103
T71231-01	VMY-1-101
HY-120946	VMY-2-95
HY-179238	CS-1-103
M22609-01	CB-103
A2067-S	PI-103
HY-P11319	RAP-103
T89348-01	HSD17B13-IN-103
T36695-01	TAS-103
MBS5757113	ICP 103

VMY-1-103

Related Products

Alternative Products

Popular Products